Our research explores the connection between time-in-range and mental health in people with type 1 and type 2 diabetes.
Given that T1D patients share many of the same comorbidities as T2D patients, doctors have been prescribing them to T1D patients ‘off label’.
This study provides real-world evidence on hypoglycemia prevalence, its effects on people, and the implications for HCP & diabetes manufacturers.
